Clinical trial
Does Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Arthroscopic Surgery Reduce Postoperative Haemarthrosis and Improve Functional Prognosis?
NCT04855877 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Arthroscopic Surgery Reduce Postoperative Haemarthrosis and Improve Functional Prognosis?
- Lead sponsor
- University of Liege
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 6, 2021
- Completion date
- July 1, 2023
- Enrollment
- 104 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anterior cruciate ligament rupture, arthroscopy, hemorrhage postoperative, total blood loss